Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression

NCT07680140 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT07680140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07680140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 4
Overall status
Recruiting
Start date
August 10, 2026
Completion date
December 31, 2028
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder, fmri, ketamine, rtms, treatment-resistant depression (trd)